|Location:||Hilton San Francisco Union Square|
|Date:||02/27/2017 - 03/02/2017|
|City, State & Country:||San Francisco, CA, USA|
The BPI West 2017 agenda is designed to break down silos across multiple departments that work in the same stage of development. With four concurrent tracks focused on early stage process development through commercial manufacturing, attendees can collectively share challenges and discuss the solutions needed to improve the speed, cost and quality of biologics development.
Pall and customers are presenting in multiple sessions. Products on display focus on Continuous Biomanufacturing, Single-use Technologies, Single-use Bioreactors, innovations in core filtration technologies, and products for Cell and GeneTherapy
Equipment/Products on Display:
Pall Life Sciences Presentations
Continuous Pre-Conference Session
Significant advances enabling fully integrated bioprocessing to become a reality – a progress report.
Holly Haughney, PhD
Continuously improving bioprocesses: Integrated continuous biomanufacturing and the continuous chromatography platform: a case study
Mark Schofield, PhD
Application of QbD Principles for Validation of Parvovirus Removal by Filtration
Morven McAlister, PhD
Cell Therapy Session
Accelerating the development of cell-based therapies: Large scale expansion of human mesenchymal stem cells